Treatment outcomes of hypofractionated radiotherapy combined with temozolomide followed by bevacizumab salvage therapy in glioblastoma patients aged > 75 years.

Ken-Ichiro MatsudaKaori SakuradaKenji NemotoTakamasa KayamaYukihiko Sonoda

Published in: International journal of clinical oncology (2018)

Hypofractionated radiotherapy combined with TMZ and BEV salvage treatment was found to be safe and effective in glioblastoma patients aged > 75 years.

Keyphrases

end stage renal disease
radiation therapy
newly diagnosed
ejection fraction
chronic kidney disease
early stage
prognostic factors
peritoneal dialysis
patient reported outcomes